Corporate Event Transcript Instant Alerts Corporate Event Transcript Instant Alerts - Page 2 September 23, 2026 6:02 AM ETTeva Eyes New Growth Phase After Securing Investment-Grade RatingsMarketBeatNYSE:TEVARead Teva Eyes New Growth Phase After Securing Investment-Grade RatingsSeptember 23, 2026 5:02 AM ETAgilent Technologies Sees Growth From China, Replacement Cycles and Lab AutomationMarketBeatNYSE:ARead Agilent Technologies Sees Growth From China, Replacement Cycles and Lab AutomationSeptember 23, 2026 4:02 AM ETGSK Targets £40B Sales as Oncology Push and £1.9B Savings Plan Take ShapeMarketBeatNYSE:GSKRead GSK Targets £40B Sales as Oncology Push and £1.9B Savings Plan Take ShapeSeptember 23, 2026 3:02 AM ETGeneral Motors Targets High End of 2026 Outlook, Sees Stronger Cash Flow in 2027MarketBeatNYSE:GMRead General Motors Targets High End of 2026 Outlook, Sees Stronger Cash Flow in 2027September 23, 2026 2:02 AM ETATI Targets $1.35B EBITDA Run Rate as Aerospace, Defense Near 70% of SalesMarketBeatNYSE:ATIRead ATI Targets $1.35B EBITDA Run Rate as Aerospace, Defense Near 70% of SalesSeptember 23, 2026 1:02 AM ETUBS Warns Swiss Capital Rules Could Cost Billions, Hurt CompetitivenessMarketBeatNYSE:UBSRead UBS Warns Swiss Capital Rules Could Cost Billions, Hurt CompetitivenessSeptember 23, 2026 12:02 AM ETUiPath Targets $2B ARR With AI Orchestration Push at Investor DayMarketBeatNYSE:PATHRead UiPath Targets $2B ARR With AI Orchestration Push at Investor DaySeptember 22, 2026 11:02 PM ETBarclays Sees Resilient U.K. Demand Fueling Loan Growth and Tech ExpansionMarketBeatNYSE:BCSRead Barclays Sees Resilient U.K. Demand Fueling Loan Growth and Tech ExpansionSeptember 22, 2026 10:02 PM ETNeurocrine Maps AI, China and Pipeline Strategy as INGREZZA Faces 2029 Price HitMarketBeatNASDAQ:NBIXRead Neurocrine Maps AI, China and Pipeline Strategy as INGREZZA Faces 2029 Price HitSeptember 22, 2026 9:02 PM ETOcular Therapeutix Eyes Q4 FDA Filing for AXPAXLI After SOL-1 SuccessMarketBeatNASDAQ:OCULRead Ocular Therapeutix Eyes Q4 FDA Filing for AXPAXLI After SOL-1 SuccessSeptember 22, 2026 8:02 PM ETBMO Sees Loan Demand Surge as Returns Rise Toward 2027 TargetsMarketBeatNYSE:BMORead BMO Sees Loan Demand Surge as Returns Rise Toward 2027 TargetsSeptember 22, 2026 7:02 PM ETQualcomm Unveils Snapdragon 8 Elite Gen 6, Bets Big on Agentic AIMarketBeatNASDAQ:QCOMRead Qualcomm Unveils Snapdragon 8 Elite Gen 6, Bets Big on Agentic AISeptember 22, 2026 6:02 PM ETAnheuser-Busch InBev Unveils ‘Reignite’ Growth Plan at Capital Markets DayMarketBeatNYSE:BUDRead Anheuser-Busch InBev Unveils ‘Reignite’ Growth Plan at Capital Markets DaySeptember 22, 2026 5:02 PM ETFastly Targets Up to $1.3B Revenue by 2029 as AI Traffic SurgesMarketBeatNASDAQ:FSLYRead Fastly Targets Up to $1.3B Revenue by 2029 as AI Traffic SurgesSeptember 22, 2026 4:02 PM ETAbeona Therapeutics Highlights ZEVASKYN Launch Momentum, Revenue Growth at H.C. WainwrightMarketBeatNASDAQ:ABEORead Abeona Therapeutics Highlights ZEVASKYN Launch Momentum, Revenue Growth at H.C. WainwrightSeptember 22, 2026 3:02 PM ETCompass Pathways Targets 2027 COMP360 Launch After Positive Phase III Depression DataMarketBeatNASDAQ:CMPSRead Compass Pathways Targets 2027 COMP360 Launch After Positive Phase III Depression DataSeptember 22, 2026 2:02 PM ETJ.B. Hunt Sees Strong Freight Demand as Rising Costs Pressure Q3 EarningsMarketBeatNASDAQ:JBHTRead J.B. Hunt Sees Strong Freight Demand as Rising Costs Pressure Q3 EarningsSeptember 22, 2026 1:02 PM ETCompass Pathways Eyes 2027 COMP360 Launch as FDA Review AdvancesMarketBeatNASDAQ:CMPSRead Compass Pathways Eyes 2027 COMP360 Launch as FDA Review AdvancesSeptember 22, 2026 12:02 PM ETCognex Acquires RealSense for $500M to Expand Robotic Vision PlatformMarketBeatNASDAQ:CGNXRead Cognex Acquires RealSense for $500M to Expand Robotic Vision PlatformSeptember 22, 2026 11:02 AM ETDraftKings Sees Strong NFL Start, Prediction Markets Surge as $1B EBITDA Target HoldsMarketBeatNASDAQ:DKNGRead DraftKings Sees Strong NFL Start, Prediction Markets Surge as $1B EBITDA Target HoldsSeptember 22, 2026 10:02 AM ETCelldex Phase III CSU Trials Hit Endpoints as Barzolvolimab Shows Durable ResponsesMarketBeatNASDAQ:CLDXRead Celldex Phase III CSU Trials Hit Endpoints as Barzolvolimab Shows Durable ResponsesSeptember 22, 2026 9:02 AM ETAnalog Devices Sees Double-Digit Growth Into 2027 on Data Center, Industrial DemandMarketBeatNASDAQ:ADIRead Analog Devices Sees Double-Digit Growth Into 2027 on Data Center, Industrial DemandSeptember 22, 2026 8:02 AM ETViking Therapeutics’ VK2735 Shows Strong Weight-Loss Retention With Monthly DosingMarketBeatNASDAQ:VKTXRead Viking Therapeutics’ VK2735 Shows Strong Weight-Loss Retention With Monthly DosingSeptember 22, 2026 7:02 AM ETCybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member BoardMarketBeatNASDAQ:HELPRead Cybin Shareholders Weigh Helus Pharma Rebrand, Eight-Member BoardSeptember 22, 2026 6:02 AM ETPfizer Refocuses Growth Strategy as New Products Offset COVID DeclineMarketBeatNYSE:PFERead Pfizer Refocuses Growth Strategy as New Products Offset COVID DeclineSeptember 22, 2026 5:02 AM ETSanofi Reviews Pipeline, Broadens Deal Hunt as It Rebuilds Research EngineMarketBeatNASDAQ:SNYRead Sanofi Reviews Pipeline, Broadens Deal Hunt as It Rebuilds Research EngineSeptember 22, 2026 4:03 AM ETLloyds Banking Group Maps 2030 Growth Plan as U.K. Consumers Stay ResilientMarketBeatNYSE:LYGRead Lloyds Banking Group Maps 2030 Growth Plan as U.K. Consumers Stay ResilientSeptember 22, 2026 3:02 AM ETTeva CEO Details Biopharma Pivot, $700M Savings Plan and Growth PipelineMarketBeatNYSE:TEVARead Teva CEO Details Biopharma Pivot, $700M Savings Plan and Growth PipelineSeptember 22, 2026 2:02 AM ETAbeona Expands ZEVASKYN Network as RDEB Launch Gains MomentumMarketBeatNASDAQ:ABEORead Abeona Expands ZEVASKYN Network as RDEB Launch Gains MomentumSeptember 22, 2026 1:02 AM ETNational Bank of Canada Eyes Commercial Growth From CWB Deal, Succession WaveMarketBeatTSE:NARead National Bank of Canada Eyes Commercial Growth From CWB Deal, Succession Wave Page 2 of 4 ‹ Most Recent1234 Earlier › Earliest » More Articles by TopicArticle TopicsAll ArticlesAIAnalyst RatingsBiotechCommunication Services SectorCongressional TradingConsumer Discretionary SectorConsumer Staples SectorDefenseDividendEarningsElectric VehicleEnergy SectorETFFinance SectorHealthcare SectorIndustrial SectorInsider TradingInvestor EducationIPOMacroMaterials SectorMergers & AcquisitionsQuantum ComputingRare Earth MineralsReal Estate SectorSemiconductorShort InterestSpaceStock IdeaStock MarketTechnology SectorUtilities SectorInstant Alert TopicsAll Instant AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
